Cellectis
Laurent Poirot serves as the SVP of Immunology and Translational Research Lead at Cellectis, where leadership in R&D focuses on developing next-generation CAR T-cells utilizing gene editing and CAR technologies. Prior experience includes positions as Head of Early Discovery and Project Leader, specializing in genome engineering in T lymphocytes for adoptive cancer immunotherapy. Laurent's background also encompasses work as an Institute Fellow at the Genomics Institute of the Novartis Research Foundation, conducting high-throughput screening and forward genetics in immune cell biology. Laurent holds a PhD in Immunology from Harvard Medical School and an additional PhD in Immunology from Université Louis Pasteur (Strasbourg I), alongside an engineering degree in Physics and Biology from École Polytechnique.
This person is not in any teams
This person is not in any offices
Cellectis
1 followers
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.